Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Biocartis NV

News headline image
Press Release Biocartis NV: Biocartis to collaborate with Mayo Clinic on breast cancer gene signatures
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis Receives FDA Approval for the Idylla™ CDx MSI Test
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis Welcomes Ben Svarczkopf as Senior Vice President of Global Marketing
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis Announces IVDR Class C CDx Certification of the Idylla™ EGFR Mutation Test
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis Announces Launch of the Brand-New Idylla™ POLE-POLD1 Mutation Assay
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis Announces Multiple Abstracts Demonstrating the Impact of Idylla™ in Oncology Diagnostics to be Presented at USCAP 2025 Annual Meeting
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis announces new data on early CAR-T vector load assessment with Idylla™ presented at ASTCT: A Potential Breakthrough in LBCL Treatment Monitoring
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis appoints Randy Polonsky as Chief Financial Officer
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis announces six Idylla™ abstracts to be presented at AMP 2024 Annual Meeting
From Biocartis NV
Via GlobeNewswire
News headline image
Press release Biocartis NV: Biocartis appoints renowned precision oncology expert, Dr. W. Michael Korn, as Chief Medical and Scientific Officer
From Biocartis NV
Via GlobeNewswire
News headline image
Press release Biocartis NV: Biocartis Welcomes Gina Wallar, PhD as Chief Business Officer and Judith Vacchino, PhD as VP Global Marketing
From Biocartis NV
Via GlobeNewswire
News headline image
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region
From Biocartis NV
Via GlobeNewswire
News headline image
Press release Biocartis Group NV: Biocartis Announces Nine Idylla™ Studies to be Published at Upcoming AMP 2022 Annual Meeting
From Biocartis NV
Via GlobeNewswire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.